Hydrocodone restrictions not coming soon, FDA says

Share this article:

Restricting access to hydrocodone painkillers will require a lengthy process unless Congress takes action, the Food and Drug Administration recently told lawmakers.

A bipartisan group of five senators and two representatives wrote to the FDA last month, urging the agency to promptly change hydrocodone painkillers such as Vicodin from Schedule III to Schedule II drugs. To do this, the Drug Enforcement Administration must receive public comment after publishing information about the change in the Federal Register, the FDA said in a March 5 response letter that has been obtained by The Hill. Regulations also require the FDA to conduct further research as part of the reclassifying process, the letter said.

The reclassification, recommended in January by an FDA advisory panel, would make it more difficult to obtain these commonly prescribed medications.

Lawmakers say hydrocodone is fueling a nationwide epidemic of prescription painkiller addiction, but critics say reclassification will make it unnecessarily hard for nursing homes and other healthcare providers to care for those in pain.

The fastest potential route to reclassification would be Congressional legislation mandating the change, the FDA said. A House staffer told The Hill such a bill is pending, but noted 14 years have already passed since Congress first asked the FDA to reclassify hydrocodone.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...